Antibacterial potency of type VI amidase effector toxins is dependent on substrate topology and cellular context

Members of the bacterial T6SS amidase effector (Tae) superfamily of toxins are delivered between competing bacteria to degrade cell wall peptidoglycan. Although Taes share a common substrate, they exhibit distinct antimicrobial potency across different competitor species. To investigate the molecula...

Full description

Bibliographic Details
Main Authors: Atanas Radkov, Anne L Sapiro, Sebastian Flores, Corey Henderson, Hayden Saunders, Rachel Kim, Steven Massa, Samuel Thompson, Chase Mateusiak, Jacob Biboy, Ziyi Zhao, Lea M Starita, William L Hatleberg, Waldemar Vollmer, Alistair B Russell, Jean-Pierre Simorre, Spencer Anthony-Cahill, Peter Brzovic, Beth Hayes, Seemay Chou
Format: Article
Language:English
Published: eLife Sciences Publications Ltd 2022-06-01
Series:eLife
Subjects:
Online Access:https://elifesciences.org/articles/79796
_version_ 1818018357328216064
author Atanas Radkov
Anne L Sapiro
Sebastian Flores
Corey Henderson
Hayden Saunders
Rachel Kim
Steven Massa
Samuel Thompson
Chase Mateusiak
Jacob Biboy
Ziyi Zhao
Lea M Starita
William L Hatleberg
Waldemar Vollmer
Alistair B Russell
Jean-Pierre Simorre
Spencer Anthony-Cahill
Peter Brzovic
Beth Hayes
Seemay Chou
author_facet Atanas Radkov
Anne L Sapiro
Sebastian Flores
Corey Henderson
Hayden Saunders
Rachel Kim
Steven Massa
Samuel Thompson
Chase Mateusiak
Jacob Biboy
Ziyi Zhao
Lea M Starita
William L Hatleberg
Waldemar Vollmer
Alistair B Russell
Jean-Pierre Simorre
Spencer Anthony-Cahill
Peter Brzovic
Beth Hayes
Seemay Chou
author_sort Atanas Radkov
collection DOAJ
description Members of the bacterial T6SS amidase effector (Tae) superfamily of toxins are delivered between competing bacteria to degrade cell wall peptidoglycan. Although Taes share a common substrate, they exhibit distinct antimicrobial potency across different competitor species. To investigate the molecular basis governing these differences, we quantitatively defined the functional determinants of Tae1 from Pseudomonas aeruginosa PAO1 using a combination of nuclear magnetic resonance and a high-throughput in vivo genetic approach called deep mutational scanning (DMS). As expected, combined analyses confirmed the role of critical residues near the Tae1 catalytic center. Unexpectedly, DMS revealed substantial contributions to enzymatic activity from a much larger, ring-like functional hot spot extending around the entire circumference of the enzyme. Comparative DMS across distinct growth conditions highlighted how functional contribution of different surfaces is highly context-dependent, varying alongside composition of targeted cell walls. These observations suggest that Tae1 engages with the intact cell wall network through a more distributed three-dimensional interaction interface than previously appreciated, providing an explanation for observed differences in antimicrobial potency across divergent Gram-negative competitors. Further binding studies of several Tae1 variants with their cognate immunity protein demonstrate that requirements to maintain protection from Tae activity may be a significant constraint on the mutational landscape of tae1 toxicity in the wild. In total, our work reveals that Tae diversification has likely been shaped by multiple independent pressures to maintain interactions with binding partners that vary across bacterial species and conditions.
first_indexed 2024-04-14T07:38:04Z
format Article
id doaj.art-e8b6e88e62cc4ba1b7e72be730157666
institution Directory Open Access Journal
issn 2050-084X
language English
last_indexed 2024-04-14T07:38:04Z
publishDate 2022-06-01
publisher eLife Sciences Publications Ltd
record_format Article
series eLife
spelling doaj.art-e8b6e88e62cc4ba1b7e72be7301576662022-12-22T02:05:37ZengeLife Sciences Publications LtdeLife2050-084X2022-06-011110.7554/eLife.79796Antibacterial potency of type VI amidase effector toxins is dependent on substrate topology and cellular contextAtanas Radkov0https://orcid.org/0000-0001-7418-279XAnne L Sapiro1https://orcid.org/0000-0002-6612-8272Sebastian Flores2Corey Henderson3Hayden Saunders4https://orcid.org/0000-0002-7582-3031Rachel Kim5https://orcid.org/0000-0003-3793-4264Steven Massa6Samuel Thompson7Chase Mateusiak8https://orcid.org/0000-0002-2890-4242Jacob Biboy9https://orcid.org/0000-0002-1286-6851Ziyi Zhao10Lea M Starita11William L Hatleberg12https://orcid.org/0000-0002-0423-7123Waldemar Vollmer13Alistair B Russell14Jean-Pierre Simorre15https://orcid.org/0000-0002-7943-1342Spencer Anthony-Cahill16Peter Brzovic17Beth Hayes18https://orcid.org/0000-0001-6633-751XSeemay Chou19https://orcid.org/0000-0002-7271-303XDepartment of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, United StatesDepartment of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, United StatesUniversity of Miami, Miami, United StatesInBios International, Seattle, United StatesDepartment of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, United StatesPacific Northwest University of Health Sciences, Yakima, United StatesDepartment of Biology, Stanford University, Stanford, United StatesDepartment of Bioengineering, Stanford University, Stanford, United StatesComputer Science Department, Washington University in St. Louis, St. Louis, United StatesCentre for Bacterial Cell Biology, Newcastle University, Newcastle upon Tyne, United KingdomDepartment of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, United StatesDepartment of Genome Sciences, University of Washington, Seattle, United States; Brotman Baty Institute for Precision Medicine, Seattle, United StatesIndependent Researcher, Pittsburg, United StatesCentre for Bacterial Cell Biology, Newcastle University, Newcastle upon Tyne, United KingdomDivision of Biological Sciences, University of California, San Diego, La Jolla, United StatesUniversité Grenoble Alpes, Grenoble, FranceChemistry Department, Western Washington University, Bellingham, United StatesDepartment of Biochemistry, University of Washington, Seattle, United StatesDepartment of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, United StatesDepartment of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, United StatesMembers of the bacterial T6SS amidase effector (Tae) superfamily of toxins are delivered between competing bacteria to degrade cell wall peptidoglycan. Although Taes share a common substrate, they exhibit distinct antimicrobial potency across different competitor species. To investigate the molecular basis governing these differences, we quantitatively defined the functional determinants of Tae1 from Pseudomonas aeruginosa PAO1 using a combination of nuclear magnetic resonance and a high-throughput in vivo genetic approach called deep mutational scanning (DMS). As expected, combined analyses confirmed the role of critical residues near the Tae1 catalytic center. Unexpectedly, DMS revealed substantial contributions to enzymatic activity from a much larger, ring-like functional hot spot extending around the entire circumference of the enzyme. Comparative DMS across distinct growth conditions highlighted how functional contribution of different surfaces is highly context-dependent, varying alongside composition of targeted cell walls. These observations suggest that Tae1 engages with the intact cell wall network through a more distributed three-dimensional interaction interface than previously appreciated, providing an explanation for observed differences in antimicrobial potency across divergent Gram-negative competitors. Further binding studies of several Tae1 variants with their cognate immunity protein demonstrate that requirements to maintain protection from Tae activity may be a significant constraint on the mutational landscape of tae1 toxicity in the wild. In total, our work reveals that Tae diversification has likely been shaped by multiple independent pressures to maintain interactions with binding partners that vary across bacterial species and conditions.https://elifesciences.org/articles/79796type VI amidase effectorpeptidoglycantopologycognate immunitydeep mutational scanninghost–microbe interaction
spellingShingle Atanas Radkov
Anne L Sapiro
Sebastian Flores
Corey Henderson
Hayden Saunders
Rachel Kim
Steven Massa
Samuel Thompson
Chase Mateusiak
Jacob Biboy
Ziyi Zhao
Lea M Starita
William L Hatleberg
Waldemar Vollmer
Alistair B Russell
Jean-Pierre Simorre
Spencer Anthony-Cahill
Peter Brzovic
Beth Hayes
Seemay Chou
Antibacterial potency of type VI amidase effector toxins is dependent on substrate topology and cellular context
eLife
type VI amidase effector
peptidoglycan
topology
cognate immunity
deep mutational scanning
host–microbe interaction
title Antibacterial potency of type VI amidase effector toxins is dependent on substrate topology and cellular context
title_full Antibacterial potency of type VI amidase effector toxins is dependent on substrate topology and cellular context
title_fullStr Antibacterial potency of type VI amidase effector toxins is dependent on substrate topology and cellular context
title_full_unstemmed Antibacterial potency of type VI amidase effector toxins is dependent on substrate topology and cellular context
title_short Antibacterial potency of type VI amidase effector toxins is dependent on substrate topology and cellular context
title_sort antibacterial potency of type vi amidase effector toxins is dependent on substrate topology and cellular context
topic type VI amidase effector
peptidoglycan
topology
cognate immunity
deep mutational scanning
host–microbe interaction
url https://elifesciences.org/articles/79796
work_keys_str_mv AT atanasradkov antibacterialpotencyoftypeviamidaseeffectortoxinsisdependentonsubstratetopologyandcellularcontext
AT annelsapiro antibacterialpotencyoftypeviamidaseeffectortoxinsisdependentonsubstratetopologyandcellularcontext
AT sebastianflores antibacterialpotencyoftypeviamidaseeffectortoxinsisdependentonsubstratetopologyandcellularcontext
AT coreyhenderson antibacterialpotencyoftypeviamidaseeffectortoxinsisdependentonsubstratetopologyandcellularcontext
AT haydensaunders antibacterialpotencyoftypeviamidaseeffectortoxinsisdependentonsubstratetopologyandcellularcontext
AT rachelkim antibacterialpotencyoftypeviamidaseeffectortoxinsisdependentonsubstratetopologyandcellularcontext
AT stevenmassa antibacterialpotencyoftypeviamidaseeffectortoxinsisdependentonsubstratetopologyandcellularcontext
AT samuelthompson antibacterialpotencyoftypeviamidaseeffectortoxinsisdependentonsubstratetopologyandcellularcontext
AT chasemateusiak antibacterialpotencyoftypeviamidaseeffectortoxinsisdependentonsubstratetopologyandcellularcontext
AT jacobbiboy antibacterialpotencyoftypeviamidaseeffectortoxinsisdependentonsubstratetopologyandcellularcontext
AT ziyizhao antibacterialpotencyoftypeviamidaseeffectortoxinsisdependentonsubstratetopologyandcellularcontext
AT leamstarita antibacterialpotencyoftypeviamidaseeffectortoxinsisdependentonsubstratetopologyandcellularcontext
AT williamlhatleberg antibacterialpotencyoftypeviamidaseeffectortoxinsisdependentonsubstratetopologyandcellularcontext
AT waldemarvollmer antibacterialpotencyoftypeviamidaseeffectortoxinsisdependentonsubstratetopologyandcellularcontext
AT alistairbrussell antibacterialpotencyoftypeviamidaseeffectortoxinsisdependentonsubstratetopologyandcellularcontext
AT jeanpierresimorre antibacterialpotencyoftypeviamidaseeffectortoxinsisdependentonsubstratetopologyandcellularcontext
AT spenceranthonycahill antibacterialpotencyoftypeviamidaseeffectortoxinsisdependentonsubstratetopologyandcellularcontext
AT peterbrzovic antibacterialpotencyoftypeviamidaseeffectortoxinsisdependentonsubstratetopologyandcellularcontext
AT bethhayes antibacterialpotencyoftypeviamidaseeffectortoxinsisdependentonsubstratetopologyandcellularcontext
AT seemaychou antibacterialpotencyoftypeviamidaseeffectortoxinsisdependentonsubstratetopologyandcellularcontext